美国布朗大学医学和流行病学终身教授

布朗全球心血管代谢病中心主任

临床营养学期刊AJCN副主编

Professor of Epidemiology and Medicine (Endocrinology) at Brown University.

Director of the Center for Global Cardiometabolic Health (CGCH)

Co-Editor of the American Journal of Clinical Nutrition

刘思敏博士现为布朗大学终身教授和布朗全球心血管代谢健康中心主任。二十多年来，刘教授的研究涉及从心血管代谢性疾病的遗传基础、分子流行病学，到临床危险度建模以及临床营养与药物干预等多个领域。率先在医院为基础的病例-对照研究中，通过实验室研发和流行病学应用生物标志物，揭示生物标志物与各种血管病发生风险的关联. 刘教授的实验室最早提出食物糖载量(dietary glycemic load)概念先后在美国CDC，Harvard，和 UCLA，作为主要负责人领导团队完成多项营养与分子流行病学研究，如妇女健康研究和医师健康研究领域之经典性工作。

Dr. Liu is currently Professor of Epidemiology and Medicine (Endocrinology) at Brown University. Dr. Liu’s research spans from basic inquiry of the genetic basis for metabolic diseases to molecular epidemiology and clinical risk modeling and interventions. He has been principal investigator of NIH-sponsored studies that cut across the fields of molecular genetics, nutrition, and clinical trials concerning the early detection and prevention of vascular disorders in diverse human populations. Recent work has been at the interface of nutrition and genomics with emphasis on understanding their interplays in affecting vascular outcomes.Using biomarkers for dietary carbohydrates, Dr. Liu and colleagues were among the first to validate dietary glycemic load (GL) in population-based studies and prospectively link high GL to increased cardiovascular risk. He has published more than 300 research reports in top-tier biomedical journals (NEJM, JAMA, Annals, Diabetes, AJHG, and AJCN), some of which are among the most-frequently cited in medicine and nutrition (total citations ~65,000, h-index=114 according to Google Scholar).Prof. Liu is an elected fellow/member of several prestigious medical societies including the American Heart Association (FAHA), the American Society of Clinical Investigation (ASCI) and American Epidemiological Society (AES).  Prof Liu has served on several advisory committees for local, national and international authorities addressing issues in medicine, nutrition and public health (WHO, NIH, CDC and MRC, including the medical Institutional Review Board at UCLA).